Factors associated with completion of the human papillomavirus vaccine series.
Neubrand
Tara P L
TP
Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Breitkopf
Carmen Radecki
CR
Rupp
Richard
R
Breitkopf
Daniel
D
Rosenthal
Susan L
SL
D000046:Academic Medical Centers; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001294:Attitude to Health; D002648:Child; D016001:Confidence Intervals; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control* / Q000523:psychology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000276:immunology; D010349:Patient Compliance / Q000706:statistics & numerical data*; D011336:Probability; D015397:Program Evaluation; D012307:Risk Factors; D013997:Time Factors; D014481:United States; D014611:Vaccination / Q000523:psychology / Q000706:statistics & numerical data; D055815:Young Adult
D053918:Papillomavirus Vaccines